SCHEMBL4354228

SCHEMBL4354228

CC(O)c1cc(Cl)cc(N(S)C(=O)Nc2ccccc2C(F)(F)F)c1O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.40
ALDH1A1 P00352 5/20 0.40
GAA P10253 2/20 0.39
HTT P42858 2/20 0.39
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.38
HPGD P15428 2/20 0.38
KMT2A Q03164 3/20 0.37
TSHR P16473 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
PAX8 Q06710 1/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36
THRB P10828 1/20 0.36
NOX1 Q9Y5S8 1/20 0.36
TRPV1 Q8NER1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4347517 0.85 GRIK1 (0.45) GRIK1GAAHTTKMT2ATSHR
SCHEMBL4349857 0.84 POLB (0.41) GRIK1ALDH1A1GAAHTTPOLB
SCHEMBL4344614 0.82 MAPT (0.40) ALDH1A1GAAHTTKMT2ANPC1
SCHEMBL4341759 0.81 P2RX1 (0.41) GRIK1HTTSMN1; SMN2
SCHEMBL4345871 0.79 GRIK1 (0.51) GRIK1GAAHTTPOLBKMT2A
SCHEMBL4345461 0.78 TSHR (0.44) ALDH1A1HTTPOLBMAPK1KMT2A
SCHEMBL4357779 0.78 HTT (0.43) GRIK1ALDH1A1GAAHTTPOLB
SCHEMBL4350861 0.78 ALDH1A1 (0.38) ALDH1A1GAAHTTHPGDKMT2A
SCHEMBL4356224 0.77 GRIK1 (0.51) GRIK1GAAHTTPOLBKMT2A
SCHEMBL4347804 0.77 KCNH2 (0.39) ALDH1A1GAAKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 GRIK1 21/4885ALDH1A1 2565/4885GAA 4010/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 GRIK1 54/4885ALDH1A1 2767/4885GAA 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.